Skip to main content

Clearstead Advisors, LLC

SEC CIK
0000842775
Latest filing
Aug 6, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q2 2026)
40
Value
$780
% of portfolio
<0.1%
Quarters held
2
Since Q2 2025
Holdings of MLTX by Clearstead Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202640$780<0.1%+40NewHolders
Q3 20250$00.0%−490−100.0%Sold outHolders
Q2 2025490$23.1K<0.1%+490NewHolders